- This multicenter study of 93 fellows from 4 multispecialty pain medicine programs compared NRMP rank-list position with later performance on the ACGME core competencies.
- Relative rank-list position was correlated with cohort-relative ACGME performance using Spearman correlation, permutation testing, and stratified bootstrap confidence intervals.
- The overall correlation was not significant (Spearman r = 0.06; 95% CI, -0.19 to 0.32; p = 0.63), and sensitivity and domain-specific analyses were also nonsignificant.
- Bottom-ranked fellows performed worse than top- and middle-ranked groups across domains, a weak signal the authors suggest may reflect flawed ranking or evaluation metrics.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This single-cell transcriptomic study profiled purified intact neurons from adult canine dorsal root ganglia using a new dissociation and sorting method with full-length FLASH-seq RNA sequencing.
- The authors identified canine sensory neuron clusters matching conserved DRG organization and compared them with human and mouse DRG datasets.
- Species-specific differences in subtype-restricted expression of IL31RA and SSTR2 were found and validated by in situ hybridization, with domestication-associated genes nonrandomly enriched in specific neurons.
- The authors present the dataset as a resource for comparative sensory neuroscience and for interpreting pain and itch therapeutic targets across species.
- Cross-sectional study of 20 healthy, physically active, full-busted women assigned female at birth, recruited at a university research center in Houston.
- Self-reported neck, back, arm pain and mastalgia were compared with estradiol, progesterone, glycated hemoglobin, anthropometric measures, and mental health indicators.
- Musculoskeletal pain, anxiety, and depression were reported as significant (P < 0.005), and estradiol, progesterone, and glycated hemoglobin were significantly associated with pain, though no effect sizes are given.
- The authors conclude that hormonal and metabolic health influence pain and that covariates such as self-reported anxiety should be considered when examining pain mechanisms.
- Prospective, nonrandomized case-control study comparing herpes zoster patients with healthy age- and sex-matched volunteers; the sample size is not stated in the abstract.
- Patients received an ultrasound-guided erector spinae plane block at the affected dermatome, with serum sampled before and after blocks.
- IL-6 and substance P/CGRP levels did not differ significantly between herpes zoster patients and controls.
- The authors report a significant post-block change (P = 0.009) in substance P and beta-endorphin, but the listed medians (24.0 and 237.8 after, 30.6 before) do not clearly match a decrease.
- This single-center cross-sectional study compared 101 adults with migraine against 101 age- and sex-matched controls using midsagittal FLAIR MRI.
- Corpus callosum genu, truncus, splenium thickness and length were measured by Witelson segmentation, then correlated with clinical measures within the migraine group.
- Migraine patients had thinner genu (10.41 vs 11.43 mm), truncus (5.91 vs 6.68 mm), and splenium (10.73 vs 11.13 mm), all P < 0.05, with no length difference.
- Genu thickness correlated with age at onset (r = 0.33), disability score (r = 0.37), and disease duration (r = -0.30), while attack frequency showed no association; the authors interpret this as cumulative remodeling.
- A retrospective cohort of 2,660 patients with chronic pelvic pain at Pelvic Rehabilitation Medicine centers across the United States, compared at baseline and about 3 months.
- The protocol was a series of six ultrasound-guided pelvic peripheral nerve blocks and trigger point injections, evaluated without a control group.
- Pain fell 48.6% (P < 0.001), 55% reached at least 50% pain improvement, and opioid use fell 45.4%, with ED and urgent care visits down 89.4%.
- The authors conclude the protocol is associated with broad improvements and call for longer-term follow-up against a control group.
- Bibliometric analysis of 580 Web of Science Core Collection publications on liposomal bupivacaine from 1993 through 2024, using VOSviewer, CiteSpace, and R.
- The study maps publication trends, country, institution, journal, and author collaborations, and emerging research themes rather than comparing a treatment with a control.
- Publications grew at an annual rate of 13.59%, with the United States leading (457 publications, 8,880 citations) and five research hotspots identified by cluster analysis.
- The authors conclude research has shifted from basic pharmaceutical development toward clinical integration in enhanced recovery protocols, and call for comparative effectiveness and cost-benefit studies.
- Single-center retrospective cohort of 382 patients with thoracic subacute herpetic neuralgia, propensity-matched into 72 pairs of burst-SCS and thoracic paravertebral block recipients.
- Burst spinal cord stimulation was compared with thoracic paravertebral block on pain, breakthrough pain, touch-evoked pain, sleep, and medication use over 12 months.
- Burst-SCS showed greater VAS improvement from discharge through 12 months, higher cure rates, and lower postherpetic neuralgia incidence at 3 months, though the abstract gives no effect sizes or CIs.
- Both procedures relieved pain and improved sleep, and the authors conclude burst-SCS had more favorable outcomes, with no difference in oral morphine equivalent dose.
- Retrospective single-center chart review of 60 adults with post-traumatic, postherpetic, or idiopathic intercostal neuralgia treated with ultrasound-guided radiofrequency between 2018 and 2025.
- Compared conventional radiofrequency ablation (n = 31) with pulsed radiofrequency (n = 29) on the intercostal nerves, with NRS pain scores at baseline, 3, and 6 months.
- Mean NRS scores were lower with conventional ablation at 3 months (2.77 vs 5.83) and 6 months (2.81 vs 6.31), both P < 0.001.
- In multivariable analysis, radiofrequency modality was the only independent predictor of 6-month response (OR 9.395; 95% CI 2.363-37.359; P = 0.001), and the authors conclude conventional ablation gave more sustained relief.
- A retrospective cohort of 80 patients at a single academic pain center compared posterior interpositional (n=33) and lateral transiliac (n=47) SI joint fusion performed from 2020 to 2025.
- Both approaches were performed by interventional pain physicians, and the study compared short-term pain scores, blood loss, complications, and revision surgery between them.
- Both groups improved mean VAS from 6.6 cm to 3.4 cm at one month, but revision for loss of efficacy was 18.2% for posterior versus 0% for lateral (P = 0.003).
- The authors reported low blood loss and complication rates for both approaches and called for prospective, adequately powered studies to define long-term outcomes.
- Retrospective cohort of 149 patients with predominantly unilateral knee OA at a tertiary pain clinic in India, treated July 2023 to August 2025 and followed for 6 months.
- Compared intra-articular PRP (n=92) with nanofat (n=57), using NPRS pain scores and the 6-minute walk test measured via the Accupedo app.
- Nanofat gave greater, sustained pain relief (P < 0.01) and functional gain (P = 0.006) than PRP; ≥50% relief odds were non-significant (adjusted OR 2.05, 95% CI 0.92 to 4.58).
- Authors conclude nanofat gives greater, longer-lasting benefit but call for randomized trials, and link baseline varus deformity ≥5° to lower odds of significant pain relief.
- Retrospective single-center study of 188 patients with lumbar spinal stenosis who received a single-level transforaminal epidural steroid injection.
- Three machine learning models (deep learning network, XGBoost, CatBoost) used nine clinical and MRI-derived variables to predict a ≥50% NRS reduction at one month.
- The deep learning model had the best validation accuracy (0.868) and AUC (0.882, 95% CI, 0.733-0.994), versus CatBoost (AUC 0.765) and XGBoost (AUC 0.662).
- The authors conclude deep learning outperformed conventional algorithms, but they call for larger multicenter studies for external validation before clinical use.
- Randomized, double-blind trial of 90 patients with lumbar disc herniation at a tertiary care center.
- Compared intradiscal ozone therapy with percutaneous lumbar nucleoplasty, assessing pain (VAS), disability (ODI), and quality of life (SF-36) at baseline, 1 month, and 12 months.
- Both groups improved significantly on VAS and ODI at 1 and 12 months (P < 0.001), with nucleoplasty showing lower scores than ozone at both time points.
- The authors conclude both procedures are effective and that nucleoplasty has superior long-term outcomes, though the abstract reports no effect sizes or confidence intervals.
- Randomized trial of 60 patients with diabetic peripheral neuropathic pain at one hospital in China, split into curved-needle (n=30) and straight-needle (n=30) lumbar sympathetic radiofrequency ablation groups.
- The comparison was curved-needle versus straight-needle technique for lumbar sympathetic ganglion radiofrequency ablation, both guided by ultrasound and fluoroscopy and combined with anhydrous ethanol.
- The curved needle group had shorter procedure time (10.6 ± 3.1 vs 15.2 ± 2.3 min, P < 0.001), fewer needle redirections (0.5 vs 4.5) and fewer bone contacts (1.0 vs 4.0), all P < 0.001.
- Success rate (96.7% vs 90.0%, P = 0.611), VAS pain scores and complications (3.33% vs 13.33%, P = 0.357) did not differ significantly, and the authors report higher satisfaction with the curved needle.
- Randomized, double-blind, placebo-controlled trial of 180 patients with moderate-to-severe knee osteoarthritis (Kellgren-Lawrence 3 or 4) at a single Indian tertiary pain clinic.
- Patients received three intraarticular injections, every 3 weeks, of hypertonic dextrose, ozone, and magnesium (Prolozone M), compared with corticosteroid or saline.
- At 24 weeks, WOMAC pain improved more than with corticosteroid (mean change -2.3, 98.3% CI -3.8 to -0.8, P<0.001, d 0.88); saline comparison is not reported in the abstract.
- The authors conclude the therapy is safe and provides clinically relevant analgesia, with early signs of chondroprotection on radiographs.
- Protocol for a planned multicenter, randomized, open-label, blinded-endpoint trial of 750 adults with moderate-to-severe herpes zoster pain and rash onset within 30 days.
- Participants will be randomized 1:1 to conventional treatment plus oral mirogabalin, titrated from 5 mg to 15 mg twice daily, or conventional treatment alone.
- No results are reported; the primary outcome is average pain intensity at week 4, with secondary outcomes including postherpetic neuralgia incidence and adverse events.
- The authors hypothesize that adding mirogabalin gives superior pain relief, to be tested over a 52-week follow-up.
- Prospective, randomized, single-center trial of 90 adults (89 completed) undergoing elective laparoscopic cholecystectomy, allocated to single-injection, multi-injection, or no-block groups.
- Ultrasound-guided unilateral subcostal TAP block was given as a single injection or as multiple injections, compared with no block.
- The multi-injection group had the lowest 24-hour tramadol use and lower VAS scores at 1, 6, and 24 hours (P<0.05), with PONV-free rates of 92% vs 64% vs 52% (P=0.007).
- The authors conclude both block types gave effective analgesia, with the multi-injection technique showing superior pain control and higher patient satisfaction (P<0.001).
- A single-center randomized controlled trial in Iran enrolled 90 patients with carpal tunnel relapse after surgery, split into three groups of 30 and followed for 12 months.
- Patients received ultrasound-guided hydrodissection with hyaluronidase 300 IU, hypertonic saline 5%, or normal saline, each combined with methylprednisolone and bupivacaine.
- All groups improved, but the hyaluronidase group had significantly greater reductions in VAS and Symptom Severity Scale scores at every follow-up (P < 0.01).
- Hyaluronidase also required fewer reinjections and reported the highest satisfaction, while hypertonic and normal saline did not differ significantly.
- This is a structured critical review of the 2024 ASIPP consensus guideline, built from literature review, evidence synthesis, and modified Delphi voting.
- It summarizes recommendations on stopping, bridging, and resuming antiplatelet and anticoagulant drugs, with 50 interventional procedures stratified by composite risk score.
- Of the 50 procedures, 19 were classed low-risk, 7 moderate-risk, and 24 high-risk, and 16 of 18 recommendations reached unanimous panel acceptance.
- The authors favor selective rather than routine cessation, especially for low-risk procedures, while acknowledging uncertainty about procedure classifications and interruption intervals.
- Systematic review and meta-analysis of 21 fluoroscopically guided RCTs on caudal, transforaminal, and interlaminar epidural injections for lumbar disc herniation, searching 2020 to March 2026.
- Trials compared local anesthetic with steroid against local anesthetic alone, or against placebo or an active control.
- Best-evidence synthesis graded local anesthetic with steroid as Level I for transforaminal and interlaminar injections and Level II for local anesthetic alone; caudal injections reached Level II for both. The abstract reports no pooled effect sizes or CIs.
- Authors note that few studies reported outcomes of at least 6 months, and that conventional dual-arm meta-analysis was feasible only for interlaminar injections.
- This 2025 ASIPP guideline summary on regenerative therapies for chronic low back pain used systematic review, GRADE appraisal, and a modified Delphi process with 33 voting panelists.
- Evidence was graded by target: lumbar intradiscal and epidural PRP and intradiscal BMAC were rated Level III, while facet and sacroiliac PRP or MSC injections were rated Level IV.
- All 19 recommendations reached 100% panel agreement; lumbar intradiscal and epidural biologics received moderate recommendations, while sacroiliac PRP and multitarget injections received low ones.
- The authors condition all lumbar biologic recommendations on definitive diagnosis, failed conservative care, FDA regulatory adherence, injectate verification, and consent covering experimental status and out-of-pocket cost.
- This is a guideline summary combining a systematic literature review from 1966 to October 2025, GRADE appraisal, and modified Delphi consensus on facet joint interventions for chronic axial spinal pain.
- It covers controlled diagnostic medial branch blocks and therapeutic options, including radiofrequency ablation, facet nerve blocks, and intraarticular injections, across the cervical, thoracic, and lumbar spine.
- Diagnostic medial branch blocks use an 80% pain-relief threshold with moderate to strong recommendations, while cervical and lumbar RFA and therapeutic nerve blocks in all regions received moderate recommendations at Level II evidence.
- Cost-utility estimates were $4,664 to $5,446 per QALY for lumbar and $4,994 to $5,364 for cervical interventions, and the authors call for more thoracic, intraarticular, and comparative research.
- This is a narrative review of PubMed literature on macrophage mechanisms in the CNS and DRG in postherpetic neuralgia, with no primary data.
- It identifies microglial activation in the spinal dorsal horn and macrophage expansion in the DRG as major proposed mechanisms underlying PHN.
- Symptomatic treatments reviewed include medications, nerve blocks, and neuromodulation, while etiological approaches focus on autologous biomaterials such as fat, BMAC, plasma, and serum.
- The authors note that autologous biomaterial therapies lack multicenter, large-sample, high-quality studies, and they call for better interventions for refractory PHN.
- This narrative review pooled 9 case report and case series articles, covering 27 amputees treated with spinal cord stimulation for pain-related symptoms.
- The review compared no alternative treatment; it examined SCS as the intervention for phantom limb pain across upper and lower limb amputations.
- Combined pain scores fell by a mean of 60.1% (SD 27.6), and only one included study assessed function before and after surgery.
- The authors conclude SCS appears to be a favorable option for phantom limb pain and may have a role in somatosensory feedback.
- This narrative health policy review synthesizes the CY 2026 final rule, CY 2027 proposed rule, and Medicare cost and utilization data, without patient-level data or statistical testing.
- It examines the CY 2026 rule's cut in indirect practice expense for facility services to 50% of the non-facility amount.
- Inflation-adjusted Medicare payment fell about 41% in interventional pain management from 2001 to 2025, while practice costs rose 59% by the Medicare Economic Index.
- The authors argue the facility/non-facility split poorly captures who bears indirect costs and propose an independent-practice modifier instead.
- Narrative update of a 2025 analysis, drawing on Medicare Trustees, MedPAC, CMS and CRFB sources through August 2026; no primary data are presented.
- Reports Medicare Advantage projected to cost $615 billion in 2026, about 14% ($76 billion) above equivalent fee-for-service spending, with coding intensity estimated at 10.3%.
- Notes that a September 2025 court ruling barred extrapolating RADV audit findings across whole contracts, and cites CRFB projections of $1.2 to $1.3 trillion in MA overpayments over 2026-2035.
- Concludes that reforms have been partly offset by litigation and incomplete implementation, and that prior-authorization burden is migrating into traditional Medicare for interventional pain procedures.
- This narrative policy review examines the CY 2027 OPPS/ASC proposed rule (CMS-1850-P) and prior Pain Physician analyses, focused on interventional pain management.
- Alongside a 2.4% ASC update, neuromodulation codes such as SCS generator insertion (+14.8%) get large proposed increases, but multiple-procedure discounts may offset them.
- Core injection-based procedures, including epidural steroid injections, facet joint injections, and facet radiofrequency ablation, are proposed to decrease by 3.8% to 4.3%.
- The authors conclude the proposed trajectory favors device-based procedures in ASCs over hospital outpatient departments, while injection-based services face compounding erosion in relative payment.
- Retrospective analysis of FDA MAUDE adverse event reports from 2016 to 2025 for SynchroMed and Prometra intrathecal pumps, with 5,423 morphine-only and 1,072 morphine-bupivacaine reports.
- Compares intrathecal morphine monotherapy with a binary morphine-bupivacaine mixture, looking at dosing and device- and medication-related adverse events.
- The binary group received a higher median morphine dose (2.20 vs 1.50 mg/day) yet had less cognitive impairment (0.56% vs 1.48%, P < 0.05); granulomas trended lower (0.65% vs 1.33%, P = 0.068).
- The authors conclude that adding bupivacaine gives a safety profile similar to morphine alone, with less cognitive impairment and a trend toward fewer granulomas.
- Narrative policy review of CMS's Ambulatory Specialty Model, a mandatory payment model covering heart failure and low back pain, with no study population or sample size reported.
- The review describes ASM's physician selection, episode-based cost adjustments by site of service, quality and PROM requirements, and Collaborative Care Arrangement rules, comparing it with MIPS and ACOs.
- The abstract reports no quantitative results; instead it weighs whether ASM is a carrot-and-stick or aversion-based policy and whether it represents innovation or limitation.
- It focuses on implications for interventional pain management, including comparisons across specialties such as neurosurgery and pain medicine, and ends with a practical action list for practices.
- Hybrid retrospective study of 175 adults with chronic neuropathic pain at one US center, plus national claims data (n = 953).
- Patients had a PNS trial, and those with at least 50% relief could receive permanent implants; outcomes were compared with baseline, not a control group.
- Mean NRS-11 pain fell from 7.2 at baseline to 1.7 at 12 months, 1.4 at 24 months, and 2.2 at 36 months (all P < 0.001), with no serious adverse events reported.
- Pain center office visits fell 54.1% in months 0-12 and 58.9% in months 13-24, with two-year cost reductions totaling $10,271.
- This policy analysis reviews the CY 2027 Medicare Physician Fee Schedule Proposed Rule alongside the prior final rule, CMS-related reports, and peer-reviewed literature.
- It examines the proposed efficiency adjustment, practice expense redesign, and mandatory Ambulatory Specialty Model as they affect independent interventional pain practices.
- The projected qualifying-APM conversion factor is $33.1693, down $0.42 (-1.19%) from CY 2026, and most interventional pain procedures face further cuts of roughly 2% to 6%.
- The authors conclude the rule widens the gap between practice costs and procedural payment, and they recommend inflation-indexed updates, rule revisions, and a distinct identifier for independent physicians.
- This health-policy analysis compares September 2025 draft Medicare LCDs for peripheral nerve injections in chronic pain with the final policies, and examines their equity implications.
- The draft policies would have limited coverage mainly to trigeminal neuralgia radiofrequency and certain corticosteroid injections, with lifetime caps; the final policies restored criteria-based coverage for several blocks.
- Four contractors published materially identical final LCDs, effective October 25, 2026, while participation in the collaborative process was reported separately from final publication.
- Pudendal, intercostal, ganglion impar, ulnar, and other peripheral-nerve procedures remain noncovered for chronic pain, and the authors highlight access implications of geographically discordant coverage.
- Prospective single-center observational cohort of 18 consecutive patients with refractory electrical storm, of whom 15 completed follow-up.
- Patients received ultrasound-guided percutaneous stellate ganglion block and bilateral cardiac sympathetic denervation, with two radiofrequency lesions followed by levobupivacaine infiltration; no comparator group was used.
- Median sustained ventricular arrhythmias fell from 4 at baseline to 0 at 3 months (p<0.01) and were 1.5 at 12 months (p=0.05).
- Transient Horner syndrome occurred in 73% of patients, and the authors conclude that BCSD is safe and effective, with a 12-month overall survival of 58%.
- This is a methodological review of in vivo fiber photometry for measuring nociceptive state across the brain and spinal cord in rodent models.
- It weighs the advantages of longitudinal, cell-type-specific recording during free movement against systematic error sources that are amplified in pain paradigms.
- Key constraints include a heterogeneous sampling volume, somatic-neuropil signal mixing, indicator kinetics that blur spiking, and motion, photobleaching, or hemodynamic artifacts that can mimic neural responses.
- The authors stress reference channels, artifact correction, behavioral alignment, and transparent reporting, and flag the parabrachial nucleus, periaqueductal gray, and anterior cingulate cortex as targets.
- This retrospective single-institution case series included 14 adults with prior lumbar decompression who later underwent basivertebral nerve ablation between 2019 and 2025.
- Pain was measured with the VAS at baseline, 4-6 weeks, 6 months, and 12 months after the ablation.
- Mean VAS fell from 7.07 to 3.21 at 12 months, with 85.7% (95% CI 57.2%-98.2%) achieving a ≥2-point decrease and 92.9% (95% CI 66.1%-99.8%) reporting functional improvement.
- No vertebral compression fractures occurred over a mean follow-up of 3.29 years, and the authors suggest assessing for a vertebrogenic pain component in persistent pain after decompression.
- Cross-sectional fMRI study of 27 women with fibromyalgia and 30 controls performing a negative emotion suppression task.
- Alexithymia was measured with the TAS and analyzed with whole-brain regressions testing group, alexithymia, and their interaction on activation and connectivity.
- Fibromyalgia showed reduced left middle frontal gyrus activation and altered amygdala, insula, and cingulate connectivity during suppression.
- Higher alexithymia strengthened anterior insula-inferior parietal connectivity across groups, and lowered amygdala-lingual connectivity only in controls.
- This is a Perspective article that reports no new data, sample, or outcomes; it argues about sham controls in acupuncture pain trials.
- It proposes random-point acupuncture, where real needling is applied at randomly chosen points unrelated to the treatment protocol, as an alternative to superficial needling or non-penetrating sham devices.
- The authors argue that sham approaches may not be physiologically inert, so they could blunt treatment-control differences, and that random-point controls could preserve blinding while allowing direct tests of acupoint specificity.
- They conclude that this design could strengthen trial rigor and clarify mechanisms of acupuncture analgesia, but this remains a proposal without empirical validation in the abstract.
- Pre-post study of 22 patients with knee osteoarthritis, assessed before treatment, at 3 weeks, and at 3 months.
- Patients received genicular nerve radiofrequency ablation, and the abstract describes no separate control group.
- Lift-up index and movement time improved significantly in both legs at 3 weeks and 3 months, while pain fell from 8.09 to 2.41 at 3 weeks and 4.18 at 3 months (p<0.0001).
- The authors conclude GNRFA contributes positively to postural stability; WOMAC function also improved, from 58.69 to 23.05 at 3 weeks and 36.15 at 3 months (p<0.001).
- Randomized trial of 451 adults with chronic low back pain recruited from primary care clinics in Massachusetts, Pennsylvania, and North Carolina, randomized 1:1.
- Participants received an 8-week telehealth-delivered mindfulness group medical visit program or usual care.
- At 6 months, PEG scores improved more with the intervention (between-group difference -0.62, 95% CI -1.02 to -0.23; P = .002), but the prespecified 1-point MCID was not met at any time point.
- Significant between-group differences were also reported at 8 weeks and 12 months, and the authors describe the program as scalable and nonpharmacologic.
- Randomized controlled trial of 84 women with fibromyalgia, assigned to music therapy (n=42) or brainwave entrainment via a BrainTap headset (n=42), with 6-month follow-up.
- Brainwave entrainment was given for 20 minutes daily, 5 days a week, for 8 weeks, and was compared against music therapy delivered on the same schedule.
- The brainwave entrainment group reduced pain on the VAS and the McGill pain questionnaire PRI total score (P = .0001), with no confidence intervals reported.
- The authors conclude that brainwave entrainment may relieve pain and improve quality of life, possibly through lower oxidative stress and BDNF levels, though music therapy also improved some measures.